Medicale reported cash from operations of -$6740.00 and free cash flow of -$6740.00 for the quarter ended Dec 2025, up 32.6% year over year. This cash flow statement covers 21 quarters of results from Dec 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||
| Net Income | -7175.00 | -6916.00 | -6547.00 | -18696.00 | -6635.00 | -6734.00 | -14354.00 | -8259.00 | -6115.00 | -8537.00 | -14227.00 | -19307.00 | -11564.00 | -10461.00 | -16881.00 | -16680.00 | -8275.00 | -5528.00 | -10670.00 | -5290.00 | |
| Cash from Discontinued OperationsCash from Discont. Ops | 600.00 | 600.00 | 800.00 | 7,600.00 | |||||||||||||||||
| Cash from OperationsCash from Ops. | -3575.00 | -3316.00 | -2947.00 | -15096.00 | -3035.00 | -2934.00 | -3554.00 | 159.00 | -5418.00 | -8240.00 | -12240.00 | -27706.00 | -31082.00 | -9288.00 | -15509.00 | -10000.00 | -4530.00 | -2021.00 | -6457.00 | -6740.00 | |
| Depreciation, Depletion & Amortization | |||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 3,000.00 | ||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 600.00 | ||||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||
| Change in Account PayablesChange Payables | 5,418.00 | -5418.00 | -8399.00 | 962.00 | 1,173.00 | 1,372.00 | 4,995.00 | 1,899.00 | 1,553.00 | 2,197.00 | -3596.00 | ||||||||||
| Change in Accured ExpensesChange Accured Exp. | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 6,115.00 | 297.00 | 1,987.00 | -20480.00 | 20,480.00 | 1,685.00 | 1,846.00 | 1,954.00 | 2,016.00 | 2,146.00 | |||
| Financing Activities | |||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 27,475.00 | 188.00 | 650.00 | 2,590.00 | 3,554.00 | 5,418.00 | 8,240.00 | 12,240.00 | 27,706.00 | 31,082.00 | 9,288.00 | 15,509.00 | 10,000.00 | 4,371.00 | 2,021.00 | 6,457.00 | 6,740.00 | ||||
| Change in Capital Stock | |||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 25,200.00 | ||||||||||||||||||||
| Additional items | |||||||||||||||||||||
| Change in Cash | 23,900.00 | -3128.00 | -2297.00 | -15096.00 | -3035.00 | -344.00 | 159.00 | -159.00 | |||||||||||||
| Free Cash FlowFCF | -3575.00 | -3316.00 | -2947.00 | -15096.00 | -3035.00 | -2934.00 | -3554.00 | 159.00 | -5418.00 | -8240.00 | -12240.00 | -27706.00 | -31082.00 | -9288.00 | -15509.00 | -10000.00 | -4530.00 | -2021.00 | -6457.00 | -6740.00 | |
| Net Cash FlowNCF | 23,900.00 | -3128.00 | -2297.00 | -15096.00 | -3035.00 | -344.00 | 5,577.00 | -5418.00 | -159.00 |